BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 30390035)

  • 21. The transcription activator steroidogenic factor-1 is preferentially expressed in the human pituitary gonadotroph.
    Asa SL; Bamberger AM; Cao B; Wong M; Parker KL; Ezzat S
    J Clin Endocrinol Metab; 1996 Jun; 81(6):2165-70. PubMed ID: 8964846
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [New pathological classification and clinical implications of pituitary neuroendocrine tumors of the 2022 WHO version].
    Xie J; Wu ZB
    Zhonghua Yi Xue Za Zhi; 2022 Dec; 102(47):3723-3726. PubMed ID: 36517420
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chromosomal instability in the prediction of pituitary neuroendocrine tumors prognosis.
    Lasolle H; Elsensohn MH; Wierinckx A; Alix E; Bonnefille C; Vasiljevic A; Cortet C; Decoudier B; Sturm N; Gaillard S; Ferrière A; Roy P; Jouanneau E; Bertolino P; Bardel C; Sanlaville D; Raverot G
    Acta Neuropathol Commun; 2020 Nov; 8(1):190. PubMed ID: 33168091
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytokeratin profiles in pituitary neuroendocrine tumors.
    Asa SL; Mete O
    Hum Pathol; 2021 Jan; 107():87-95. PubMed ID: 33098891
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A specific antibody to detect transcription factor T-Pit: a reliable marker of corticotroph cell differentiation and a tool to improve the classification of pituitary neuroendocrine tumours.
    Sjöstedt E; Bollerslev J; Mulder J; Lindskog C; Pontén F; Casar-Borota O
    Acta Neuropathol; 2017 Oct; 134(4):675-677. PubMed ID: 28823042
    [No Abstract]   [Full Text] [Related]  

  • 26. Immune Landscape of Pituitary Tumors Reveals Association Between Macrophages and Gonadotroph Tumor Invasion.
    Principe M; Chanal M; Ilie MD; Ziverec A; Vasiljevic A; Jouanneau E; Hennino A; Raverot G; Bertolino P
    J Clin Endocrinol Metab; 2020 Nov; 105(11):. PubMed ID: 32785693
    [TBL] [Abstract][Full Text] [Related]  

  • 27. GATA3: a multispecific but potentially useful marker in surgical pathology: a systematic analysis of 2500 epithelial and nonepithelial tumors.
    Miettinen M; McCue PA; Sarlomo-Rikala M; Rys J; Czapiewski P; Wazny K; Langfort R; Waloszczyk P; Biernat W; Lasota J; Wang Z
    Am J Surg Pathol; 2014 Jan; 38(1):13-22. PubMed ID: 24145643
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Free alpha-subunit and intact TSH secretion in vitro are closely associated in human somatotroph adenomas.
    Aylwin SJ; King A; Blenke A; Geddes JF; Wood DF; Monson JP; Burrin JM
    Eur J Endocrinol; 1998 Oct; 139(4):378-86. PubMed ID: 9820613
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mixed Sparsely Granulated Lactotroph and Densely Granulated Somatotroph Pituitary Neuroendocrine Tumor Expands the Spectrum of Neuroendocrine Neoplasms in Ovarian Teratomas: the Role of Pituitary Neuroendocrine Cell Lineage Biomarkers.
    Hodgson A; Pakbaz S; Shenouda C; Francis JA; Mete O
    Endocr Pathol; 2020 Sep; 31(3):315-319. PubMed ID: 32632841
    [No Abstract]   [Full Text] [Related]  

  • 30. Serotonin, ATRX, and DAXX Expression in Pituitary Adenomas: Markers in the Differential Diagnosis of Neuroendocrine Tumors of the Sellar Region.
    Casar-Borota O; Botling J; Granberg D; Stigare J; Wikström J; Boldt HB; Kristensen BW; Pontén F; Trouillas J
    Am J Surg Pathol; 2017 Sep; 41(9):1238-1246. PubMed ID: 28719461
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Histopathological classification of non-functioning pituitary neuroendocrine tumors.
    Manojlovic-Gacic E; Engström BE; Casar-Borota O
    Pituitary; 2018 Apr; 21(2):119-129. PubMed ID: 29275530
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular, functional, and histopathological classification of the pituitary neuroendocrine neoplasms.
    Inomoto C; Tahara S; Oyama K; Kimura M; Matsuno A; Teramoto A; Osamura RY
    Brain Tumor Pathol; 2021 Jul; 38(3):183-188. PubMed ID: 34269950
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stress-response proteins in human pituitary adenomas. Expression of heat-shock protein 72 (HSP-72).
    Kontogeorgos G; Stefaneanu L; Kovacs K
    Endocrine; 1997 Feb; 6(1):25-9. PubMed ID: 9225112
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunolocalization of Pit-1 in gonadotroph nuclei is indicative of the transdifferentiation of gonadotroph to lactotroph cells in prolactinomas induced by estrogen.
    Mukdsi JH; De Paul AL; Muñoz S; Aoki A; Torres AI
    Histochem Cell Biol; 2004 Jun; 121(6):453-62. PubMed ID: 15221415
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of metastatic neuroendocrine neoplasms to the breast and primary invasive mammary carcinomas with neuroendocrine differentiation.
    Mohanty SK; Kim SA; DeLair DF; Bose S; Laury AR; Chopra S; Mertens RB; Dhall D
    Mod Pathol; 2016 Aug; 29(8):788-98. PubMed ID: 27125358
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical Implications of the New WHO Classification 2017 for Pituitary Tumors.
    Saeger W; Koch A
    Exp Clin Endocrinol Diabetes; 2021 Mar; 129(3):146-156. PubMed ID: 33690870
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Unveiling the identities of null cell tumours: Epigenomics corroborate subtle histological cues in pituitary neuroendocrine tumour/adenoma classification.
    Dottermusch M; Schüller U; Hagel C; Saeger W
    Neuropathol Appl Neurobiol; 2023 Feb; 49(1):e12870. PubMed ID: 36527335
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Update from the 5th Edition of the World Health Organization Classification of Head and Neck Tumors: Overview of the 2022 WHO Classification of Head and Neck Neuroendocrine Neoplasms.
    Mete O; Wenig BM
    Head Neck Pathol; 2022 Mar; 16(1):123-142. PubMed ID: 35312985
    [TBL] [Abstract][Full Text] [Related]  

  • 39. How to Classify the Pituitary Neuroendocrine Tumors (PitNET)s in 2020.
    Trouillas J; Jaffrain-Rea ML; Vasiljevic A; Raverot G; Roncaroli F; Villa C
    Cancers (Basel); 2020 Feb; 12(2):. PubMed ID: 32098443
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phox2B is a sensitive and reliable marker of paraganglioma-Phox2B immunohistochemistry in diagnosis of neuroendocrine neoplasms.
    Manethova M; Gerykova L; Faistova H; Drugda J; Hacova M; Hornychova H; Ryska A; Gabalec F; Soukup J
    Virchows Arch; 2023 Apr; 482(4):679-686. PubMed ID: 36656393
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.